Published in Int J Nanomedicine on July 04, 2017
Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 8.37
Design and development of polymers for gene delivery. Nat Rev Drug Discov (2005) 6.79
Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer (2011) 3.10
Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano (2010) 2.36
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov (2014) 1.61
Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano (2011) 1.46
Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm (2011) 1.42
Microenvironment and tumor cell plasticity: an easy way out. Cancer Lett (2013) 1.26
Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano (2011) 1.18
Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin Drug Deliv (2012) 1.16
Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerfaces (2011) 1.14
Cancer nanomedicine: from targeted delivery to combination therapy. Trends Mol Med (2015) 1.13
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett (2012) 1.09
Recent advances in delivery of drug-nucleic acid combinations for cancer treatment. J Control Release (2013) 1.08
Role of integrated cancer nanomedicine in overcoming drug resistance. Adv Drug Deliv Rev (2013) 1.03
Hyalurondiase: both a tumor promoter and suppressor. Semin Cancer Biol (2008) 1.02
Branched and linear poly(ethylene imine)-based conjugates: synthetic modification, characterization, and application. Chem Soc Rev (2012) 0.95
The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials (2013) 0.93
Stimuli-sensitive nanopreparations for combination cancer therapy. J Control Release (2014) 0.92
Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol (2016) 0.91
PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials (2012) 0.91
"Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv Drug Deliv Rev (2015) 0.90
Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles. Biomaterials (2014) 0.90
Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin. Cancer Gene Ther (2006) 0.89
Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer. Biomaterials (2015) 0.85
Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption. Biomaterials (2013) 0.85
pH-responsive zwitterionic copolypeptides as charge conversional shielding system for gene carriers. J Control Release (2013) 0.84
pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery. Int J Nanomedicine (2015) 0.83
Co-delivery of drugs and plasmid DNA for cancer therapy. Adv Drug Deliv Rev (2015) 0.82
A tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy. Acta Biomater (2013) 0.81
Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel. Int J Pharm (2013) 0.81
PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo. J Control Release (2015) 0.80
Coupling of a bifunctional peptide R13 to OTMCS-PEI copolymer as a gene vector increases transfection efficiency and tumor targeting. Int J Nanomedicine (2014) 0.79
Bioreducible PEI-functionalized glycol chitosan: A novel gene vector with reduced cytotoxicity and improved transfection efficiency. Carbohydr Polym (2016) 0.79
Co-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrier. Colloids Surf B Biointerfaces (2015) 0.78
Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain. J Colloid Interface Sci (2015) 0.77
pH-sensitive controlled release of doxorubicin from polyelectrolyte multilayers. Colloids Surf B Biointerfaces (2014) 0.77
Design of starch-graft-PEI polymers: an effective and biodegradable gene delivery platform. Biomacromolecules (2014) 0.77
Hyaluronic acid-based drug conjugates: state-of-the-art and perspectives. J Biomed Nanotechnol (2014) 0.76
Hyaluronated nanoparticles with pH- and enzyme-responsive drug release properties. Colloids Surf B Biointerfaces (2014) 0.76
Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells. Mol Pharm (2016) 0.75
New technology: nanotechnology targets cancer cells. Nat Rev Clin Oncol (2013) 0.75